Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Cerus (CERS) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Pathogen Reduced Red Blood CellsSickle Cell DiseasePhase IINot Yet RecruitingBiotin-Acridine Red Cell Exchange KineticsAug 27, 2025
Intercept RbcsTransfusion Reaction, HemolyticPhase IINot Yet RecruitingChallenge Transfusion of INTERCEPT Pathogen Reduced Red Blood Cells (RBCs) in Subjects With or Without Pre-existing Antibodies to INTERCEPT RBCsAug 26, 2025
Intercept Blood System For Rbcs, Infusion Of Autologous Radiolabeled RbcsHealthy SubjectsPhase IIRecruitingA Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1Apr 28, 2025―
Intercept Blood System For Platelets With Led IlluminatorHealthy SubjectsPhase IINot Yet RecruitingA Study to Assess Recovery and Survival of Radiolabeled Apheresis Platelet Components Treated with the INTERCEPT Blood System for Platelets with LED Illuminator.Nov 18, 2024―
Intercept Treated PlateletsHealthyPhase IICompletedIn Vivo Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Apheresis Platelet Components Suspended in 100% Plasma Stored for up to 7 DaysJul 09, 2019―
Control, InterceptAnemiaPhase IIICompletedStudy to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery PatientsMar 02, 2018―
Intercept Blood System For Red Blood Cells, Conventional (Control)AnemiaPhase IIIRecruitingINTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted InfectionsJan 26, 2017―
Autologous Apheresis Platelet Components, Prepared With The Intercept Blood System For Platelets., Autologous Apheresis Conventional Untreated Platelet ComponentsHealthyPhase IITerminatedA Randomized, Multi-center, Open-label, Paired Controlled, Crossover In Vivo StudyDec 02, 2015―
Intercept Treated PlateletsHealthyPhase IICompletedA Controlled, In Vivo, Pilot Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Treated 7-Day Stored Apheresis Platelet Components in 35% Plasma and 65% InterSol and 7-Day Stored Apheresis Platelet Components in 100% PlasmaNov 10, 2014―
Intercept PlasmaAcute Ebola Virus DiseasePhase ITerminatedA Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus DiseaseNov 04, 2014―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Cerus Corporation (CERS) have in its pipeline
Cerus CERS is currently developing the following drugs: Pathogen Reduced Red Blood Cells, Intercept Rbcs, Intercept Blood System For Rbcs, Infusion Of Autologous Radiolabeled Rbcs, Intercept Blood System For Platelets With Led Illuminator, Intercept Treated Platelets, Control, Intercept, Intercept Blood System For Red Blood Cells, Conventional (Control), Autologous Apheresis Platelet Components, Prepared With The Intercept Blood System For Platelets., Autologous Apheresis Conventional Untreated Platelet Components, Intercept Plasma, S-303 Treated Red Blood Cells (Rbcs), Conventional, Untreated Red Blood Cells, S303 Red Blood Cells (Rbcs), Conventional, Untreated Red Blood Cells (Rbcs). These drug candidates are in various stages of clinical development as the company works toward FDA approval.